Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Philips Respironics
Age
5–8
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
• Asthmatic children between the ages of 5 and 8 followed at Arkansas Children's Hospital.
* The subjects must be available to complete the study.
* The subject's parent(s) and/or the subject's legal guardian must provide written informed consent to participate in the study.
* The subject must provide assent when older than 7 years old.
* The subjects should have used a pMDI VHC previously and be able to use a VHC with mouthpiece.
* The subjects should have been prescribed fluticasone or another inhaled corticosteroid delivered via a pMDI VHC combination.
* Clinically stable asthma.
* Cooperative, i.e., subject should be able to follow and understand instructions.
* The subject must satisfy the study investigator about his/her fitness to participate in the study.
You may not be if
Clinically significant respiratory disease in the previous 4 weeks.
Participation in any other clinical trial in the previous 4 weeks.
Lack of cooperation, subject cannot follow and understand instructions.
Clareo Health | Drug Delivery Via Pressurized Metered-dose Inhaler and Valved Holding Chamber in Asthmatic Children: Determination of Delivered Dose Following Coordinated and Uncoordinated Use
